- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Futura Medical Share News (FUM)
Share News for Futura Medical (FUM)
| Share Price: 71.50 | Bid: 70.00 | Ask: 73.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
Futura's erection-boosting condom gets EU backing
Mon, 20th Jun 2011 12:00
LONDON, June 20 (Reuters) - British company Futura Medical said its erection-enhancing condom
The CSD500 condom has a small amount of gel in its tip that dilates the arteries and increases blood flow to the penis, resulting in a firmer and bigger erection, studies by Futura published in 2008 showed.
Futura said on Monday products usually took about a month to receive CE mark certification after recommendation. The mark would enable the condom to be sold in 29 European territories and a number of other non-European countries.
Nomura Code analyst Michael King said news of the long-awaited approval should be very reassuring for Futura's shareholders.
He said under the agreement, Reckitt Benckiser had six months from approval to launch the product, which could achieve a successful market share of 5 percent, generating annual royalties of about 10 million pounds ($16 million) for Futura.
Futura shares were up 4.5 percent at 1045 GMT, while shares in Reckitt Benckiser were flat.
(Reporting by Paul Sandle; Editing by Dan Lalor) ($1 = 0.6198 pound) Keywords: FUTURA/CONDOM
(paul.sandle@reuters.com; +44 20 7542-6843; Reuters Messaging: paul.sandle.reuters.com@reuters.net)
COPYRIGHT
Copyright Thomson Reuters 2011. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
LONDON, June 20 (Reuters) - British company Futura Medical said its erection-enhancing condom
, licensed to Reckitt Benckiser for sale under its Durex brand, had been recommended for European approval.
The CSD500 condom has a small amount of gel in its tip that dilates the arteries and increases blood flow to the penis, resulting in a firmer and bigger erection, studies by Futura published in 2008 showed.
Futura said on Monday products usually took about a month to receive CE mark certification after recommendation. The mark would enable the condom to be sold in 29 European territories and a number of other non-European countries.
Nomura Code analyst Michael King said news of the long-awaited approval should be very reassuring for Futura's shareholders.
He said under the agreement, Reckitt Benckiser had six months from approval to launch the product, which could achieve a successful market share of 5 percent, generating annual royalties of about 10 million pounds ($16 million) for Futura.
Futura shares were up 4.5 percent at 1045 GMT, while shares in Reckitt Benckiser were flat.
(Reporting by Paul Sandle; Editing by Dan Lalor) ($1 = 0.6198 pound) Keywords: FUTURA/CONDOM
(paul.sandle@reuters.com; +44 20 7542-6843; Reuters Messaging: paul.sandle.reuters.com@reuters.net)
COPYRIGHT
Copyright Thomson Reuters 2011. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
BRIEF-Futura Medical says talks on re-licensing of csd500 progressing well
LONDON, Jan 7 (Reuters) - Futura Medical PLC: * Statement re share price movement * Confirms negotiations are progressing well for the[7 Jan '13]
BRIEF-Futura Medical raises 2.08 mln stg
LONDON, Sept 14 (Reuters) - Futura Medical PLC: * Placing to raise £2.08 million ((London Equities Newsroom; +44 20 7542 7717))[14 Sep '12]
BRIEF-Futura Medical notes CE mark for csd500 condom
LONDON, Aug 8 (Reuters) - Futura Medical PLC: * Award of the ce mark certificate to reckitt benckiser plc for csd500, the company's[8 Aug '11]
Futura's erection-boosting condom gets EU backing
LONDON, June 20 (Reuters) - British company Futura Medical said its erection-enhancing condom, licensed to Reckitt Benckiser for sale under its[20 Jun '11]
BRIEF-Futura Medical raises 3 mln stg via placing
LONDON, March 11 (Reuters) - Futura Medical PLC: * Placing to raise £3.20 million ((London Equities Newsroom; +44 20 7542 7717))[11 Mar '11]
BRIEF-Futura Medical signs marketing deal with Ansell
LONDON, Feb 7 (Reuters) - Futura Medical PLC: * Agreement with ansell for the commercialisation of pet500 * Will receive a significant[7 Feb '11]
BRIEF-Futura Medical sees short delay in condom CE mark
LONDON, Jan 18 (Reuters) - Futura Medical PLC: * Regulatory authority has minor points ahead of the award of the ce mark for csd500[18 Jan '11]
BRIEF-Futura Medical signs development agreement with GSK
LONDON, June 30 (Reuters) - Futura Medical PLC: * Signed a development agreement with glaxosmithkline (gsk) for development of tpr100[30 Jun '10]
